US Patent Issued to EIRGEN PHARMA on Nov. 25 for "Stabilized modified release vitamin D formulation and method of administering same" (Canadian, American Inventors)

ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,478,631, issued on Nov. 25, was assigned to EIRGEN PHARMA LTD. (Waterford, Ireland).

"Stabilized modified release vitamin D formulation and method of administering same" was invented by Jay A. White (Newmarket, Canada), Samir P. Tabash (Whitby, Canada), Sammy A. Agudoawu (Mississauga, Canada) and Joel Z. Melnick (Evanston, Ill.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A stabilized formulation for controlled release of a vitamin D compound is disclosed. The formulation can comprise one or both of 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 and a stabilizing compound. The stabilized formulations exhibit a stable dissolution profile following expos...